We propose a novel mechanism showing that cancers expressing low levels of NEDD4L enhance autophagy and mitochondrial metabolism via deregulating the protein activity of ULK1 and a glutamine transporter, and so promote tumor development. The gene discussed is NEDD4L; the disease is neoplasm.